Back
Full-text
Journal article

EAACI/ENDA Position Paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents.

  • Kidon M The Pediatric Allergy Clinic, Sheba Medical Center, Tel Hashomer and the Sackler Faculty of Medicine, Safra Children's Hospital, Tel Aviv University, Tel Aviv, Israel.
  • Blanca-Lopez N Allergy Service, Infanta Leonor University Hospital, Madrid, Spain.
  • Gomes E Allergy and Clinical Immunology Department, CHP, Porto, Portugal.
  • Terreehorst I Department of ENT and Pediatrics, Academisch Medisch Centrum, Amsterdam, The Netherlands.
  • Tanno L Hospital Sírio Libanês, São Paulo, Brazil.
  • Ponvert C Paediatric Pulmonology & Allergy Service, Assistance Publique-Hôpitaux de Paris, Hôpital Necker-Enfants Malades, Paris, France.
  • Chin CW Department of Paediatrics, Kandang Kerbau Women's and Children's Hospital, Singapore, Singapore.
  • Caubet JC Geneva University Hospital, Geneva, Switzerland.
  • Soyer O Pediatric Allergy Department, School of Medicine, Hacettepe University, Ankara, Turkey.
  • Mori F Allergy Unit, Department of Pediatric Medicine, Anna Meyer Children's University Hospital, Florence, Italy.
  • Blanca M Allergy Service, Infanta Leonor University Hospital, Spain University, Madrid, Spain.
  • Atanaskovic-Markovic M University of Belgrade, Faculty of Medicine, University Children's Hospital, Belgrade, Serbia.
Show more…
  • 2018-04-26
Published in:
  • Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology. - 2018
Adolescent
Child
Drug Hypersensitivity
EAACI
ENDA
NSAIDs
Non Steroidal Anti Inflammatory Drugs
Position Paper
Adolescent
Allergens
Anaphylaxis
Animals
Anti-Inflammatory Agents, Non-Steroidal
Child
Child, Preschool
Cross Reactions
Desensitization, Immunologic
Drug Hypersensitivity
Expert Testimony
Female
Humans
Male
Practice Guidelines as Topic
Risk Factors
Skin Tests
English Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used in the pediatric population as antipyretics/analgesics and anti-inflammatory medications. Hypersensitivity (HS) reactions to NSAID in this age group, while similar to adults, have unique diagnostic and management issues. Although slowly accumulating, published data in this age group are still relatively rare and lacking a unifying consensus. This work is a summary of current knowledge and consensus recommendations utilizing both published data and expert opinion from the European Network of Drug Allergy (ENDA) and the Drug Hypersensitivity interest group in the European Academy of Allergy and Clinical Immunology (EAACI). This position paper summarizes diagnostic and management guidelines for children and adolescents with NSAIDs hypersensitivity.
Language
  • English
Open access status
bronze
Identifiers
Persistent URL
https://sonar.ch/global/documents/134066
Statistics
Document views: 20 File downloads:
  • fulltext.pdf: 0